From structure to the dynamic regulation of a molecular switch: A journey over 3 decades
Open accessThe DOI matches its Crossref record; 5 of the 5 references it cites were found in a registry or an index.
Abstract
It is difficult to imagine where the signaling community would be today without the Protein Data Bank. This visionary resource, established in the 1970s, has been an essential partner for sharing information between academics and industry for over 3 decades. We describe here the history of our journey with the protein kinases using cAMP-dependent protein kinase as a prototype. We summarize what we have learned since the first structure, published in 1991, why our journey is still ongoing, and why it has been essential to share our structural information. For regulation of kinase activity, we focus on the cAMP-binding protein kinase regulatory subunits. By exploring full-length macromolecular complexes, we discovered not only allostery but also an essential motif originally attributed to crystal packing. Massive genomic data on disease mutations allows us to now revisit crystal packing as a treasure chest of possible protein:protein interfaces where the biological significance and disease relevance can be validated. It provides a new window into exploring dynamic intrinsically disordered regions that previously were deleted, ignored, or attributed to crystal packing. Merging of crystallography with cryo-electron microscopy, cryo-electron tomography, NMR, and millisecond molecular dynamics simulations is opening a new world for the signaling community where those structure coordinates, deposited in the Protein Data Bank, are just a starting point! It is difficult to imagine where the signaling community would be today without the Protein Data Bank. This visionary resource, established in the 1970s, has been an essential partner for sharing information between academics and industry for over 3 decades. We describe here the history of our journey with the protein kinases using cAMP-dependent protein kinase as a prototype. We summarize what we have learned since the first structure, published in 1991, why our journey is still ongoing, and why it has been essential to share our structural information. For regulation of kinase activity, we focus on the cAMP-binding protein kinase regulatory subunits. By exploring full-length macromolecular complexes, we discovered not only allostery but also an essential motif originally attributed to crystal packing. Massive genomic data on disease mutations allows us to now revisit crystal packing as a treasure chest of possible protein:protein interfaces where the biological significance and disease relevance can be validated. It provides a new window into exploring dynamic intrinsically disordered regions that previously were deleted, ignored, or attributed to crystal packing. Merging of crystallography with cryo-electron microscopy, cryo-electron tomography, NMR, and millisecond molecular dynamics simulations is opening a new world for the signaling community where those structure coordinates, deposited in the Protein Data Bank, are just a starting point! The scientific community is enormously grateful to the visionary leaders of the early crystallography community who realized how important it would be to have an international resource where all new structures would be deposited and validated. Max Perutz, Michael Rossmann, and Fred Richards were among the early pioneers who championed the PDB concept. In 1971 the Protein Data Bank (PDB) was officially announced in Nature New Biology (1Crystallography: Protein Data Bank.Nat. New Biol. 1971; 233: 223Crossref PubMed Scopus (39) Google Scholar) as a joint venture between Brookhaven National Laboratory under the direction of Walter Hamilton and the Cambridge Crystal Data Center, founded by Olga Kennard, with an initial holding of seven protein structures. Helen Berman, who was also involved with the initial establishment of the PDB, led the transformation of the PDB into a modern, worldwide database in 1998. The determination and dedication of these two pioneering women, along with the visionary leadership of Perutz, Richards, Rossmann, and others, was essential to the founding of the PDB and to the development of the modern PDB. From an initial concept as a static archive to the development of a dynamic research tool, the development of the PDB allows the research community to leverage the investments made by many funding agencies across disciplinary and national boundaries and solidifies the concept that these structures belong to the community and not just to the individual laboratory that solved the structure. It represents an exciting commitment to science and to the scientific community. Of course, no one envisioned the ways in which this community would explode along with the technologies in computing over the ensuing decades. We describe here the impact that this vision has had on the signaling community using cAMP-dependent protein kinase (PKA) as a model. We not only highlight the wide-ranging benefits that have evolved but also emphasize future challenges and new opportunities to build on for the future as our understa
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
AKAP signalling complexes: focal points in space and time
Wong, W., & Scott, J. D. (2004) · Nature Reviews Molecular Cell Biology · doi:10.1038/nrm1527 · Cited by 1,073 · cited 1×
“In addition to trapping the Rdimer, the DD domain serves as a scaffold for A kinase anchoring proteins (AKAPs), which each contain an amphipathic helix that docks the kinase to specific sites within the cell (24).”
BackgroundMasterson, L. R., Shi, L., Metcalfe, E., Gao, J., Taylor, S. S., & Veglia, G. (2011) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1102701108 · Cited by 160
Self-citationA dynamic hydrophobic core orchestrates allostery in protein kinases
Kim, J., Ahuja, L. G., Chao, F.-A., Xia, Y., McClendon, C. L., Kornev, A. P., Taylor, S. S., & Veglia, G. (2017) · Science Advances · doi:10.1126/sciadv.1600663 · Cited by 116
Self-citationDynamic allostery-based molecular workings of kinase:peptide complexes
Ahuja, L. G., Aoto, P. C., Kornev, A. P., Veglia, G., & Taylor, S. S. (2019) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1900163116 · Cited by 49
Self-citationZooming in on protons: Neutron structure of protein kinase A trapped in a product complex
Gerlits, O., Weiss, K. L., Blakeley, M. P., Veglia, G., Taylor, S. S., & Kovalevsky, A. (2019) · Science Advances · doi:10.1126/sciadv.aav0482 · Cited by 30
Self-citation
Cited by
Burley, S. K., Bhikadiya, C., Bi, C., Bittrich, S., Chao, H., Chen, L., Craig, P. A., Crichlow, G. V., Dalenberg, K., Duarte, J. M., et al. (2023) · Nucleic Acids Research · doi:10.1093/nar/gkac1077 · Cited by 887
Properties of FDA-approved small molecule protein kinase inhibitors: A 2024 update
Roskoski, R. (2024) · Pharmacological Research · doi:10.1016/j.phrs.2024.107059 · Cited by 383
Properties of FDA-approved small molecule protein kinase inhibitors: A 2023 update
Roskoski, R. (2023) · Pharmacological Research · doi:10.1016/j.phrs.2022.106552 · Cited by 273
Espinoza-Corral, R., & Lundquist, P. K. (2022) · Journal of Biological Chemistry · doi:10.1016/j.jbc.2022.101762 · Cited by 20
Structure and regulation of full-length human leucine-rich repeat kinase 1
Metcalfe, R. D., Martinez Fiesco, J. A., Bonet-Ponce, L., Kluss, J. H., Cookson, M. R., & Zhang, P. (2023) · Nature Communications · doi:10.1038/s41467-023-40532-2 · Cited by 8
Metadata
- Authors
- Taylor, S. S., Wu, J., Bruystens, J. G. H., Del Rio, J. C., Lu, T.-W., Kornev, A. P., & Ten Eyck, L. F.
- Venue
- Journal of Biological Chemistry
- Publisher
- Elsevier BV
- Published
- 2021-01
- Volume
- 296
- Pages
- 100746
- ISSN
- 0021-9258 (ISSN-L)
- OpenAlex
- W3159857500
- Cited by
- 100
- References
- 5
- FWCI
- 5.03
- Type
- journal article
- Language
- en
- Open access
- gold
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.